Arbutus Biopharma Corp Accounts Payable and Other Accrued Liabilities
Arbutus Biopharma Corp (ABUS) had Accounts Payable and Other Accrued Liabilities of $7.50 million as of 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2015-11-05
- 2015-09-30: Accounts Payable and Other Accrued Liabilities $7.50M.
- 2014-12-31: Accounts Payable and Other Accrued Liabilities $9.33M.
| Period end | Accounts Payable and Other Accrued Liabilities |
|---|---|
| 2015-09-30 | $7.50M 10-Q · filed 2015-11-05 |
| 2014-12-31 | $9.33M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |